Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response

Cell Reports

Volumn 4, Issue 4, 2013, Pages 689-696

  Behrendt, Rayk ^a   Schumann, Tina ^a   Gerbaulet, Alexander ^a   Nguyen, Laura A ^b   Schubert, Nadja ^a   Alexopoulou, Dimitra ^c   Berka, Ursula ^a   Lienenklaus, Stefan ^d   Peschke, Katrin ^a   Gibbert, Kathrin ^e   Wittmann, Sabine ^f   Lindemann, Dirk ^a   Weiss, Siegfried ^d   Dahl, Andreas ^c   Naumann, Ronald ^g   Dittmer, Ulf ^e   Kim, Baek ^h,i   Mueller, Werner ^j   Gramberg, Thomas ^f   Roers, Axel ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^h Kyung Hee University   (South Korea)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF MANCHESTER   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; EXONUCLEASE; INTERFERON; PHOSPHATASE; SAM DOMAIN AND HD DOMAIN 1 PROTEIN; UNCLASSIFIED DRUG;

AICARDI GOUTIERES SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HYDROLYSIS; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RETROVIRUS; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; VIRUS REPLICATION;

ANIMALS; DENDRITIC CELLS; DEOXYRIBONUCLEOTIDES; FRIEND MURINE LEUKEMIA VIRUS; HIV-1; INTERFERON-BETA; LYMPHOCYTES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOMERIC GTP-BINDING PROTEINS; RECEPTOR, INTERFERON ALPHA-BETA; REVERSE TRANSCRIPTION; TRANSCRIPTION, GENETIC; UP-REGULATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS;

EID: 84883277795     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.07.037     Document Type: Article

References (53)

1. Anders S., Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010, 11:R106.
2. Baldauf H.M., Pan X., Erikson E., Schmidt S., Daddacha W., Burggraf M., Schenkova K., Ambiel I., Wabnitz G., Gramberg T., et al. SAMHD1 restricts HIV-1 infection in resting CD4(+) Tcells. Nat. Med. 2012, 18:1682-1687.
3. Banchereau J., Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006, 25:383-392.
4. Beck-Engeser G.B., Eilat D., Wabl M. An autoimmune disease prevented by anti-retroviral drugs. Retrovirology 2011, 8:91.
5. Beloglazova N., Flick R., Tchigvintsev A., Brown G., Popovic A., Nocek B., Yakunin A.F. Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction. J.Biol. Chem. 2013, 288:8101-8110.
6. Berger A., Sommer A.F., Zwarg J., Hamdorf M., Welzel K., Esly N., Panitz S., Reuter A., Ramos I., Jatiani A., et al. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection. PLoS Pathog. 2011, 7:e1002425.
7. Biswas N., Wang T., Ding M., Tumne A., Chen Y., Wang Q., Gupta P. ADAR1 is a novel multi targeted anti-HIV-1 cellular protein. Virology 2012, 422:265-277.
8. Cribier A., Descours B., Valadao A.L., Laguette N., Benkirane M. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep. 2013, 3:1036-1043.
9. Crow Y.J., Rehwinkel J. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum. Mol. Genet. 2009, 18:R130-R136.
10. Crow Y.J., Hayward B.E., Parmar R., Robins P., Leitch A., Ali M., Black D.N., van Bokhoven H., Brunner H.G., Hamel B.C., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat. Genet. 2006, 38:917-920.
11. Crow Y.J., Leitch A., Hayward B.E., Garner A., Parmar R., Griffith E., Ali M., Semple C., Aicardi J., Babul-Hirji R., et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat. Genet. 2006, 38:910-916.
12. Descours B., Cribier A., Chable-Bessia C., Ayinde D., Rice G., Crow Y., Yatim A., Schwartz O., Laguette N., Benkirane M. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells. Retrovirology 2012, 9:87.
13. Diamond T.L., Roshal M., Jamburuthugoda V.K., Reynolds H.M., Merriam A.R., Lee K.Y., Balakrishnan M., Bambara R.A., Planelles V., Dewhurst S., Kim B. Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J.Biol. Chem. 2004, 279:51545-51553.
14. Dittmer U., Brooks D.M., Hasenkrug K.J. Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms. J.Virol. 1998, 72:6554-6558.
15. Doria M., Neri F., Gallo A., Farace M.G., Michienzi A. Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Res. 2009, 37:5848-5858.
16. Gall A., Treuting P., Elkon K.B., Loo Y.M., Gale M., Barber G.N., Stetson D.B. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 2012, 36:120-131.
17. Goldstone D.C., Ennis-Adeniran V., Hedden J.J., Groom H.C., Rice G.I., Christodoulou E., Walker P.A., Kelly G., Haire L.F., Yap M.W., et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 2011, 480:379-382.
18. Habegger L., Sboner A., Gianoulis T.A., Rozowsky J., Agarwal A., Snyder M., Gerstein M. RSEQtools: a modular framework to analyze RNA-Seq data using compact, anonymized data summaries. Bioinformatics 2011, 27:281-283.
19. Hartner J.C., Walkley C.R., Lu J., Orkin S.H. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat. Immunol. 2009, 10:109-115.
20. Hasan M., Koch J., Rakheja D., Pattnaik A.K., Brugarolas J., Dozmorov I., Levine B., Wakeland E.K., Lee-Kirsch M.A., Yan N. Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes. Nat. Immunol. 2013, 14:61-71.
21. Hasenkrug K.J., Brooks D.M., Robertson M.N., Srinivas R.V., Chesebro B. Immunoprotective determinants in friend murine leukemia virus envelope protein. Virology 1998, 248:66-73.
22. Hiller B., Achleitner M., Glage S., Naumann R., Behrendt R., Roers A. Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity. J.Exp. Med. 2012, 209:1419-1426.
23. Hofmann H., Logue E.C., Bloch N., Daddacha W., Polsky S.B., Schultz M.L., Kim B., Landau N.R. The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleus. J.Virol. 2012, 86:12552-12560.
24. Hrecka K., Hao C., Gierszewska M., Swanson S.K., Kesik-Brodacka M., Srivastava S., Florens L., Washburn M.P., Skowronski J. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011, 474:658-661.
25. Kim B., Nguyen L.A., Daddacha W., Hollenbaugh J.A. Tight interplay among SAMHD1 protein level, cellular dNTP levels, and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophages. J.Biol. Chem. 2012, 287:21570-21574.
26. Laguette N., Sobhian B., Casartelli N., Ringeard M., Chable-Bessia C., Ségéral E., Yatim A., Emiliani S., Schwartz O., Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474:654-657.
27. Lahouassa H., Daddacha W., Hofmann H., Ayinde D., Logue E.C., Dragin L., Bloch N., Maudet C., Bertrand M., Gramberg T., et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 2012, 13:223-228.
28. Lee-Kirsch M.A., Chowdhury D., Harvey S., Gong M., Senenko L., Engel K., Pfeiffer C., Hollis T., Gahr M., Perrino F.W., et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J.Mol. Med. 2007, 85:531-537.
29. Lee-Kirsch M.A., Gong M., Chowdhury D., Senenko L., Engel K., Lee Y.A., de Silva U., Bailey S.L., Witte T., Vyse T.J., et al. Mutations in thegene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 2007, 39:1065-1067.
30. Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25:1754-1760.
31. Lienenklaus S., Cornitescu M., Zietara N., Lyszkiewicz M., Gekara N., Jablonska J., Edenhofer F., Rajewsky K., Bruder D., Hafner M., et al. Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta invivo. J.Immunol. 2009, 183:3229-3236.
32. Morita M., Stamp G., Robins P., Dulic A., Rosewell I., Hrivnak G., Daly G., Lindahl T., Barnes D.E. Gene-targeted mice lacking the Trex1 (DNase III) 3'->5' DNA exonuclease develop inflammatory myocarditis. Mol. Cell. Biol. 2004, 24:6719-6727.
33. Pascual V., Farkas L., Banchereau J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr. Opin. Immunol. 2006, 18:676-682.
34. Phuphuakrat A., Kraiwong R., Boonarkart C., Lauhakirti D., Lee T.H., Auewarakul P. Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins. J.Virol. 2008, 82:10864-10872.
35. Powell R.D., Holland P.J., Hollis T., Perrino F.W. Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J.Biol. Chem. 2011, 286:43596-43600.
36. Ramantani G., Kohlhase J., Hertzberg C., Innes A.M., Engel K., Hunger S., Borozdin W., Mah J.K., Ungerath K., Walkenhorst H., et al. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome. Arthritis Rheum. 2010, 62:1469-1477.
37. Ramantani G., Häusler M., Niggemann P., Wessling B., Guttmann H., Mull M., Tenbrock K., Lee-Kirsch M.A. Aicardi-Goutières syndrome and systemic lupus erythematosus (SLE) in a 12-year-old boy with SAMHD1 mutations. J.Child Neurol. 2011, 26:1425-1428.
38. Rampazzo C., Miazzi C., Franzolin E., Pontarin G., Ferraro P., Frangini M., Reichard P., Bianchi V. Regulation by degradation, a cellular defense against deoxyribonucleotide pool imbalances. Mutat. Res. 2010, 703:2-10.
39. Ravenscroft J.C., Suri M., Rice G.I., Szynkiewicz M., Crow Y.J. Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus. Am. J. Med. Genet. A. 2011, 155A:235-237.
40. Reijns M.A., Rabe B., Rigby R.E., Mill P., Astell K.R., Lettice L.A., Boyle S., Leitch A., Keighren M., Kilanowski F., et al. Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development. Cell 2012, 149:1008-1022.
41. Rice G., Newman W.G., Dean J., Patrick T., Parmar R., Flintoff K., Robins P., Harvey S., Hollis T., O'Hara A., et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am. J. Hum. Genet. 2007, 80:811-815.
42. Rice G., Patrick T., Parmar R., Taylor C.F., Aeby A., Aicardi J., Artuch R., Montalto S.A., Bacino C.A., Barroso B., et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am. J. Hum. Genet. 2007, 81:713-725.
43. Rice G.I., Bond J., Asipu A., Brunette R.L., Manfield I.W., Carr I.M., Fuller J.C., Jackson R.M., Lamb T., Briggs T.A., et al. Mutations involved inAicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat. Genet. 2009, 41:829-832.
44. Rice G.I., Kasher P.R., Forte G.M., Mannion N.M., Greenwood S.M., Szynkiewicz M., Dickerson J.E., Bhaskar S.S., Zampini M., Briggs T.A., et al. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat. Genet. 2012, 44:1243-1248.
45. Rönnblom L., Alm G.V., Eloranta M.L. The type I interferon system in the development of lupus. Semin. Immunol. 2011, 23:113-121.
46. Skarnes W.C., Rosen B., West A.P., Koutsourakis M., Bushell W., Iyer V., Mujica A.O., Thomas M., Harrow J., Cox T., et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 2011, 474:337-342.
47. Stetson D.B., Ko J.S., Heidmann T., Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
48. Tervo H.M., Goffinet C., Keppler O.T. Mouse T-cells restrict replication of human immunodeficiency virus at the level of integration. Retrovirology 2008, 5:58.
49. Tüngler V., Staroske W., Kind B., Dobrick M., Kretschmer S., Schmidt F., Krug C., Lorenz M., Chara O., Schwille P., Lee-Kirsch M.A. Single-stranded nucleic acids promote SAMHD1 complex formation. J.Mol. Med. 2013, 91:759-770.
50. White T.E., Brandariz-Nuñez A., Valle-Casuso J.C., Amie S., Nguyen L., Kim B., Brojatsch J., Diaz-Griffero F. Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1. Virology 2013, 436:81-90.
51. White T.E., Brandariz-Nuñez A., Valle-Casuso J.C., Amie S., Nguyen L.A., Kim B., Tuzova M., Diaz-Griffero F. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe 2013, 13:441-451.
52. Yan N., Regalado-Magdos A.D., Stiggelbout B., Lee-Kirsch M.A., Lieberman J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat. Immunol. 2010, 11:1005-1013.
53. Yang Y.G., Lindahl T., Barnes D.E. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 2007, 131:873-886.